Tem8-Peptide und Impfstoffe damit

European patent · EP2508601 · Deleted

Register entry

Publication number
EP2508601
Application number
EP12166766
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 10, 2008
Published
Oct 10, 2012
Granted
Nov 5, 2014
Deleted
Apr 30, 2015
Reason
Annual fee unpaid
IPC classes
C12N 15/00 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
C07K 7/06 (2006.01)
C07K 14/705 (2006.01)
C12N 5/00 (2006.01)
Priority
US 911194 P 11.04.2007
Divided from
EP08738544
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 18, 2015

    Deleted, fee unpaid

    Published in Swissreg on 18.11.2015

  2. Nov 25, 2014

    Agent entered

    Representative
    Vossius & Partner, Nadelberg 3, 4051 Basel

    Published in Swissreg on 25.11.2014

  3. Nov 5, 2014

    Granted

    Published in Swissreg on 05.11.2014

Parties

Holder

OncoTherapy Science, Inc.

Oncotherapy Science, Inc.

2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012, JP

Agent

Vossius & Partner

Nadelberg 3, 4051 Basel

Inventor

Tsunoda, Takuya

Kanagawa, 213-0012, JP

Osawa, Ryuji

Kanagawa, 213-0012, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.